AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 63 filers reported holding AKCEA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $179,000 | +29.7% | 9,840 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $138,000 | +29.0% | 10,062 | +35.0% | 0.00% | 0.0% |
| Q1 2020 | $107,000 | -20.1% | 7,453 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $134,000 | +10.7% | 7,882 | +0.4% | 0.00% | – |
| Q3 2019 | $121,000 | -34.6% | 7,853 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $185,000 | -22.9% | 7,908 | -6.7% | 0.00% | 0.0% |
| Q1 2019 | $240,000 | -5.1% | 8,480 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $253,000 | -14.5% | 8,396 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $296,000 | +50.3% | 8,460 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $197,000 | -19.9% | 8,307 | -13.4% | 0.00% | 0.0% |
| Q1 2018 | $246,000 | +40.6% | 9,588 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $175,000 | -36.4% | 10,102 | +1.7% | 0.00% | 0.0% |
| Q3 2017 | $275,000 | – | 9,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |